Field Medical's Field PULSE Trial Shows Promising Results in Heart Ablation Technology#USA#Carlsbad#Field_Medical#PFA#FieldForce_PFA
Field Medical's Field PULSE Trial Shows Promising Results in Heart Ablation Technology
Field Medical, Inc. presents groundbreaking results from the Field PULSE trial, highlighting a 94.2% efficacy in pulmonary vein isolation for cardiac procedures.
third-news.com
September 21, 2026 at 10:37 AM
Field Medical's Field PULSE Trial Shows Promising Results in Heart Ablation Technology#USA#Carlsbad#Field_Medical#PFA#FieldForce_PFA
Revolutionary Outcomes Unveiled in Field Medical's First-in-Human Trial of Pulsed Field Ablation Technology#USA#Carlsbad#Field_Medical#FieldForce#PFA_System
Revolutionary Outcomes Unveiled in Field Medical's First-in-Human Trial of Pulsed Field Ablation Technology
Field Medical's trial results reveal a remarkable 94.2% durability for pulmonary vein isolation. This innovative approach showcases procedural efficiency and enhances patient outcomes.
third-news.com
September 20, 2026 at 2:59 PM
Revolutionary Outcomes Unveiled in Field Medical's First-in-Human Trial of Pulsed Field Ablation Technology#USA#Carlsbad#Field_Medical#FieldForce#PFA_System
Field Medical's Innovative Ablation Technique Shows Promising 12-Month Results in Clinical Trial#USA#Carlsbad#Field_Medical#PFA#HRX_2026
Field Medical's Innovative Ablation Technique Shows Promising 12-Month Results in Clinical Trial
Field Medical, Inc. presents its groundbreaking clinical trial results at HRX 2026, showcasing a notable 94.2% effectiveness in pulmonary vein isolation through advanced high-voltage pulsed field ablation.
third-news.com
September 20, 2026 at 7:46 PM
Field Medical's Innovative Ablation Technique Shows Promising 12-Month Results in Clinical Trial#USA#Carlsbad#Field_Medical#PFA#HRX_2026
Field Medical's First-In-Human Field PULSE Trial Shows Promising 12-Month Heart Ablation Outcomes#USA#Atlanta#Field_Medical#PFA_System#Field_PULSE
Field Medical's First-In-Human Field PULSE Trial Shows Promising 12-Month Heart Ablation Outcomes
Field Medical, Inc. reveals that its Field PULSE trial demonstrates a remarkable 94.2% durability for pulmonary vein isolation at 12 months, improving cardiac arrhythmia treatment.
third-news.com
September 20, 2026 at 2:59 PM
Field Medical's First-In-Human Field PULSE Trial Shows Promising 12-Month Heart Ablation Outcomes#USA#Atlanta#Field_Medical#PFA_System#Field_PULSE
Field Medical Appoints Mark A. Turco, MD, as New CEO to Lead Growth Initiatives#USA#Cardiff-by-the-Sea#Field_Medical#PFA_Solutions#Mark_Turco
Field Medical Appoints Mark A. Turco, MD, as New CEO to Lead Growth Initiatives
Field Medical, Inc. has announced the appointment of Mark A. Turco, MD, as their new CEO. He brings over 30 years of relevant experience in medical technology and clinical trials.
third-news.com
March 16, 2026 at 2:02 PM
Field Medical Appoints Mark A. Turco, MD, as New CEO to Lead Growth Initiatives#USA#Cardiff-by-the-Sea#Field_Medical#PFA_Solutions#Mark_Turco
Field Medical Appoints Experienced Doctor Mark A. Turco as New CEO for Growth Strategy#USA#Field_Medical#Cardiff-by-the-Sea,_California#PFA_Technology#Mark_Turco
Field Medical Appoints Experienced Doctor Mark A. Turco as New CEO for Growth Strategy
Field Medical, Inc. has appointed Dr. Mark A. Turco as CEO, bringing over 30 years of medical technology leadership to the company focused on PFA solutions for arrhythmias.
third-news.com
March 16, 2026 at 2:02 PM
Field Medical Appoints Experienced Doctor Mark A. Turco as New CEO for Growth Strategy#USA#Field_Medical#Cardiff-by-the-Sea,_California#PFA_Technology#Mark_Turco
Field Medical Appoints Dr. Mark A. Turco as New CEO to Drive Growth Initiatives#USA#medical_technology#Cardiff-by-the-Sea#Field_Medical#Mark_A._Turco
Field Medical Appoints Dr. Mark A. Turco as New CEO to Drive Growth Initiatives
Field Medical has officially appointed Dr. Mark A. Turco as CEO. With over 30 years of experience, he is set to lead the company's growth and innovation.
third-news.com
March 16, 2026 at 2:01 PM
Field Medical Appoints Dr. Mark A. Turco as New CEO to Drive Growth Initiatives#USA#medical_technology#Cardiff-by-the-Sea#Field_Medical#Mark_A._Turco
Mark A. Turco, MD, Appointed CEO of Field Medical to Drive Growth#USA#medical_technology#Cardiff-by-the-Sea#Field_Medical#Mark_Turco
Mark A. Turco, MD, Appointed CEO of Field Medical to Drive Growth
Field Medical, Inc. announces Mark A. Turco, MD, as its new CEO, aiming to spearhead the development of innovative cardiovascular technologies.
third-news.com
March 16, 2026 at 2:01 PM
Mark A. Turco, MD, Appointed CEO of Field Medical to Drive Growth#USA#medical_technology#Cardiff-by-the-Sea#Field_Medical#Mark_Turco
Field Medical Appoints Dr. Mark A. Turco as New CEO to Drive Growth and Innovation#United_States#Field_Medical#Cardiff-by-the-Sea,_California#Mark_A._Turco#PFA_Solutions
Field Medical Appoints Dr. Mark A. Turco as New CEO to Drive Growth and Innovation
Field Medical has announced the appointment of Dr. Mark A. Turco as its new CEO, aiming to enhance its medical technology solutions and accelerate growth.
third-news.com
March 16, 2026 at 2:00 PM
Field Medical Appoints Dr. Mark A. Turco as New CEO to Drive Growth and Innovation#United_States#Field_Medical#Cardiff-by-the-Sea,_California#Mark_A._Turco#PFA_Solutions
Field Medical Unveils Groundbreaking Clinical Trial Results at AF Symposium 2026#USA#Boston#Field_Medical#AF_Symposium#PFA_Technology
Field Medical Unveils Groundbreaking Clinical Trial Results at AF Symposium 2026
Field Medical, Inc. presents significant clinical trial findings regarding their Pulse Ablation technology for complex cardiac arrhythmias during the AF Symposium 2026, showcasing remarkable advancements.
third-news.com
February 6, 2026 at 5:44 PM
Field Medical Unveils Groundbreaking Clinical Trial Results at AF Symposium 2026#USA#Boston#Field_Medical#AF_Symposium#PFA_Technology
Field Medical Unveils Pioneering Field PULSE Trial Results at 2026 AF Symposium#USA#Boston#Field_Medical#PFA_Technology#FieldForce_System
Field Medical Unveils Pioneering Field PULSE Trial Results at 2026 AF Symposium
Field Medical presents groundbreaking results from the Field PULSE trial at the 2026 AF Symposium, showcasing innovative ablation techniques.
third-news.com
February 6, 2026 at 4:26 PM
Field Medical Unveils Pioneering Field PULSE Trial Results at 2026 AF Symposium#USA#Boston#Field_Medical#PFA_Technology#FieldForce_System
Field Medical Unveils Groundbreaking PULSE Study Insights at AF Symposium 2026#USA#Boston#Field_Medical#AF_Symposium#PULSE_Study
Field Medical Unveils Groundbreaking PULSE Study Insights at AF Symposium 2026
Field Medical, Inc. showcases innovative findings from the PULSE study on pulsed field ablation techniques at the AF Symposium 2026 in Boston.
third-news.com
February 6, 2026 at 5:36 AM
Field Medical Unveils Groundbreaking PULSE Study Insights at AF Symposium 2026#USA#Boston#Field_Medical#AF_Symposium#PULSE_Study
Field Medical Unveils Groundbreaking Trial Results for Cardiac Ablation Technology at AF Symposium 2026#USA#Boston#Field_Medical#FieldForce#AF_Symposium
Field Medical Unveils Groundbreaking Trial Results for Cardiac Ablation Technology at AF Symposium 2026
Field Medical, Inc. showcases late-breaking trial data for their pulsed field ablation technology, revolutionizing cardiac arrhythmia treatment at AF Symposium 2026.
third-news.com
February 5, 2026 at 10:50 PM
Field Medical Unveils Groundbreaking Trial Results for Cardiac Ablation Technology at AF Symposium 2026#USA#Boston#Field_Medical#FieldForce#AF_Symposium
Field Medical Unveils Latest Trial Results for PFA Technology at AF Symposium 2026#USA#Boston#Field_Medical#AF_Symposium#PFA_Technology
Field Medical Unveils Latest Trial Results for PFA Technology at AF Symposium 2026
Field Medical, Inc. presented groundbreaking results from the Field PULSE study, showcasing innovations in pulsed field ablation technology during AF Symposium 2026.
third-news.com
February 5, 2026 at 10:50 PM
Field Medical Unveils Latest Trial Results for PFA Technology at AF Symposium 2026#USA#Boston#Field_Medical#AF_Symposium#PFA_Technology
Field Medical to Showcase Innovative Technology at J.P. Morgan Healthcare Conference#USA#San_Francisco#J.P._Morgan#Field_Medical#PFA_Technology
Field Medical to Showcase Innovative Technology at J.P. Morgan Healthcare Conference
Field Medical Inc., a clinical-stage firm, will present its cutting-edge pulsed field ablation technology at the upcoming J.P. Morgan Healthcare Conference in San Francisco.
third-news.com
January 12, 2026 at 3:53 PM
Field Medical to Showcase Innovative Technology at J.P. Morgan Healthcare Conference#USA#San_Francisco#J.P._Morgan#Field_Medical#PFA_Technology
Field Medical to Present Its Innovative Cardiac Ablation Technology at J.P. Morgan's Annual Healthcare Conference#USA#San_Francisco#Field_Medical#FieldForce#cardiac_ablation
Field Medical to Present Its Innovative Cardiac Ablation Technology at J.P. Morgan's Annual Healthcare Conference
Field Medical Inc. is set to unveil its groundbreaking cardiac ablation platform at the 44th J.P. Morgan Annual Healthcare Conference.
third-news.com
January 12, 2026 at 3:53 PM
Field Medical to Present Its Innovative Cardiac Ablation Technology at J.P. Morgan's Annual Healthcare Conference#USA#San_Francisco#Field_Medical#FieldForce#cardiac_ablation
Field Medical Inc. Showcases Innovative Technology at J.P. Morgan Healthcare Conference#Healthcare_Conference#Field_Medical#PFA_Platform
Field Medical Inc. Showcases Innovative Technology at J.P. Morgan Healthcare Conference
Field Medical Inc. is set to present its groundbreaking pulsed field ablation platform at the upcoming J.P. Morgan Healthcare Conference, highlighting advancements in cardiac treatments.
third-news.com
January 12, 2026 at 3:52 PM
Field Medical Inc. Showcases Innovative Technology at J.P. Morgan Healthcare Conference#Healthcare_Conference#Field_Medical#PFA_Platform
Field Medical Set to Showcase Groundbreaking Technology at J.P. Morgan Healthcare Conference#USA#San_Francisco#Field_Medical#FieldForce#Ablation_System
Field Medical Set to Showcase Groundbreaking Technology at J.P. Morgan Healthcare Conference
Field Medical Inc. announces participation in the J.P. Morgan Healthcare Conference, introducing their innovative pulsed field ablation platform.
third-news.com
January 12, 2026 at 3:52 PM
Field Medical Set to Showcase Groundbreaking Technology at J.P. Morgan Healthcare Conference#USA#San_Francisco#Field_Medical#FieldForce#Ablation_System
Field Medical Unveils Promising Results of First VCAS Human Trial for Ventricular Ablation#United_States#New_York#Field_Medical#FieldForce#VCAS_trial
Field Medical Unveils Promising Results of First VCAS Human Trial for Ventricular Ablation
Field Medical's FieldForce™ Ablation System shows significant promise in treating ventricular tachycardia, presenting 82% reduction in recurrences and 98% decrease in episodes.
third-news.com
October 10, 2025 at 8:51 PM
Field Medical Unveils Promising Results of First VCAS Human Trial for Ventricular Ablation#United_States#New_York#Field_Medical#FieldForce#VCAS_trial
Field Medical's Groundbreaking Study Shows Promising Results for VT Treatment Using FieldForce™ System#USA#FieldForce™#Ventricular_Tachycardia#Cardiff-by-the-Sea#Field_Medical
Field Medical's Groundbreaking Study Shows Promising Results for VT Treatment Using FieldForce™ System
Recent findings from a trial using Field Medical's FieldForce™ Pulsed Field Ablation System reveal significant success in treating ventricular tachycardia, showcasing an 82% success rate.
third-news.com
October 10, 2025 at 8:41 PM
Field Medical's Groundbreaking Study Shows Promising Results for VT Treatment Using FieldForce™ System#USA#FieldForce™#Ventricular_Tachycardia#Cardiff-by-the-Sea#Field_Medical
Promising Outcomes Revealed for FieldForce™ In-Vivo Trial in Vascular Ablation#USA#FieldForce™#Cardiff-by-the-Sea#Field_Medical#VCAS
Promising Outcomes Revealed for FieldForce™ In-Vivo Trial in Vascular Ablation
New insights from the six-month outcomes of the VCAS trial highlight Field Medical, Inc.'s innovative FieldForce™ Ablation System's potential impact on ventricular tachycardia treatment.
third-news.com
October 10, 2025 at 8:39 PM
Promising Outcomes Revealed for FieldForce™ In-Vivo Trial in Vascular Ablation#USA#FieldForce™#Cardiff-by-the-Sea#Field_Medical#VCAS
Groundbreaking Results from Field Medical's FieldForce™ System for Ventricular Tachycardia Ablation#USA#Philadelphia#Field_Medical#FieldForce#VT
Groundbreaking Results from Field Medical's FieldForce™ System for Ventricular Tachycardia Ablation
Field Medical, Inc. has made significant strides in cardiac care with the VCAS study, revealing 82% absence of VT/VF recurrence using their FieldForce™ system.
third-news.com
October 10, 2025 at 8:38 PM
Groundbreaking Results from Field Medical's FieldForce™ System for Ventricular Tachycardia Ablation#USA#Philadelphia#Field_Medical#FieldForce#VT
Field Medical Presents Breakthrough Clinical Trial Data at VT Symposium 2025#United_States#Philadelphia#Field_Medical#FieldForce#VT_Symposium
Field Medical Presents Breakthrough Clinical Trial Data at VT Symposium 2025
Field Medical Inc. shares groundbreaking results from its first six months of clinical trials at the VT Symposium 2025 in Philadelphia.
third-news.com
October 9, 2025 at 4:23 PM
Field Medical Presents Breakthrough Clinical Trial Data at VT Symposium 2025#United_States#Philadelphia#Field_Medical#FieldForce#VT_Symposium
Field Medical Shares Groundbreaking Six-Month Data at VT Symposium 2025 on Innovative Therapy for Ventricular Tachycardia#USA#Philadelphia#Field_Medical#FieldForce#VT_Symposium
Field Medical Shares Groundbreaking Six-Month Data at VT Symposium 2025 on Innovative Therapy for Ventricular Tachycardia
Field Medical, Inc. is set to present its first six-month data on ground-breaking ventricular tachycardia therapy at the VT Symposium 2025, showcasing innovations in cardiac care.
third-news.com
October 9, 2025 at 12:51 PM
Field Medical Shares Groundbreaking Six-Month Data at VT Symposium 2025 on Innovative Therapy for Ventricular Tachycardia#USA#Philadelphia#Field_Medical#FieldForce#VT_Symposium
Field Medical Unveils Revolutionary 6-Month Data for VT Treatment at Upcoming Symposium#USA#Philadelphia#Field_Medical#FieldForce#VT_Symposium
Field Medical Unveils Revolutionary 6-Month Data for VT Treatment at Upcoming Symposium
Field Medical, Inc. will present groundbreaking data on its FieldForce™ Ablation System at the VT Symposium 2025, highlighting its innovative approach to ventricular tachycardia treatment.
third-news.com
October 9, 2025 at 12:50 PM
Field Medical Unveils Revolutionary 6-Month Data for VT Treatment at Upcoming Symposium#USA#Philadelphia#Field_Medical#FieldForce#VT_Symposium